GWP
WST icon

Gen-Wealth Partners’s West Pharmaceutical WST Stock Holding History

Gen-Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Sell
1,106
-163
-13% -$49.8K 0.11% 157
2026
Q1 		$318K Buy
1,269
+48
+4% +$11.9K 0.1% 189
2025
Q4 		$336K Sell
1,221
-681
-36% -$186K 0.11% 199
2025
Q3 		$499K Sell
1,902
-8
-0.4% -$1.94K 0.17% 147
2025
Q2 		$418K Sell
1,910
-43
-2% -$9.19K 0.16% 151
2025
Q1 		$437K Buy
1,953
+77
+4% +$21.2K 0.18% 146
2024
Q4 		$614K Buy
1,876
+31
+2% +$9.76K 0.26% 95
2024
Q3 		$578K Buy
1,845
+615
+50% +$188K 0.25% 105
2024
Q2 		$405K Buy
1,230
+131
+12% +$46.3K 0.2% 129
2024
Q1 		$435K Buy
+1,099
New +$407K 0.22% 125

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Gen-Wealth Partners's WST Position: Q2 2026 in Review

Gen-Wealth Partners reduced its West Pharmaceutical (WST) stake by 13% in Q2 2026, selling an estimated $49.8K and leaving 1,106 shares worth $397K. The position accounts for 0.11% of the portfolio, ranked #157.

Gen-Wealth Partners first reported a position in WST in Q1 2024 and has held it in 10 quarters since. The position peaked at $614K in Q4 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Gen-Wealth Partners held 1,106 shares of West Pharmaceutical worth $397K as of Q2 2026.
  • Gen-Wealth Partners sold 163 West Pharmaceutical shares in Q2 2026, an estimated $49.8K.
  • West Pharmaceutical made up 0.11% of Gen-Wealth Partners's portfolio in Q2 2026, its #157 holding.
  • Gen-Wealth Partners first reported a position in West Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • Gen-Wealth Partners's West Pharmaceutical position peaked at $614K in Q4 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.